Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
PubMed (GeneRIF) for id: 400456
4 results
Results by year
Filters applied: . Clear all
Page 1
LncRNA LINC01197 inhibited the formation of calcium oxalate-induced kidney stones by regulating miR-516b-5p/SIRT3/FOXO1 signaling pathway.
Cell Tissue Res. 2023 May;392(2):553-563. doi: 10.1007/s00441-022-03734-6. Epub 2023 Jan 23.
Cell Tissue Res. 2023.
PMID: 36688989
LETR1 is a lymphatic endothelial-specific lncRNA governing cell proliferation and migration through KLF4 and SEMA3C.
Ducoli L, Agrawal S, Sibler E, Kouno T, Tacconi C, Hon CC, Berger SD, Müllhaupt D, He Y, Kim J, D'Addio M, Dieterich LC, Carninci P, de Hoon MJL, Shin JW, Detmar M.
Ducoli L, et al.
Nat Commun. 2021 Feb 10;12(1):925. doi: 10.1038/s41467-021-21217-0.
Nat Commun. 2021.
PMID: 33568674
Free PMC article.
Item in Clipboard
Clinical significance of CA 19.9 and LINC01197 in pancreatic cancer.
Jia YH, Zheng WW, Ye ZH.
Jia YH, et al.
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2358-2367. doi: 10.26355/eurrev_202003_20503.
Eur Rev Med Pharmacol Sci. 2020.
PMID: 32196587
Free article.
Item in Clipboard
FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
Ling J, Wang F, Liu C, Dong X, Xue Y, Jia X, Song W, Li Q.
Ling J, et al.
J Exp Clin Cancer Res. 2019 Apr 26;38(1):179. doi: 10.1186/s13046-019-1174-3.
J Exp Clin Cancer Res. 2019.
PMID: 31027497
Free PMC article.
Item in Clipboard
Cite
Cite